Completed PHASE4 NCT00179413

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

Phase IV Study of Long Term Peg-Intron for Patients Who Have Failed to Respond to Rebetron/Interferon With Advanced Fibrosis and Cirrhosis Secondary to Hepatitis C- The Copilot Trial

Sponsor: Beth Israel Deaconess Medical Center

Conditions Advanced Fibrosis Cirrhosis Hepatitis C Virus

Interventions Colchicine PEG -Intron

Updated 7 times since 2017 Last updated: Jun 11, 2017 Started: Jan 15, 2000 Primary completion: Dec 31, 2009 Completion: Mar 3, 2010

A PHASE4 clinical study on Advanced Fibrosis and Cirrhosis, this trial is completed. The trial is conducted by Beth Israel Deaconess Medical Center and has accumulated 7 data snapshots since 2000. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Aug 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2017 — Aug 2017 [monthly]

Unknown Status PHASE4

First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Deaconess Medical Center
Schering-Plough

Data source: Beth Israel Deaconess Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Bakersfield, United States , Baltimore, United States , Birmingham, United States , Boston, United States , Bradenton, United States , Burlington, United States , Danbury, United States , Denver, United States , Detroit, United States and 32 more locations